Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
J Antimicrob Chemother
; 74(4): 1056-1061, 2019 04 01.
Article
em En
| MEDLINE
| ID: mdl-30590533
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Triazóis
/
Aspergilose Pulmonar
/
Antifúngicos
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2019